Boehringer Ingelheim caps inhaler out-of-pocket costs at $35 after political pressure
After Senate Democrats on the health committee pressed inhaler manufacturers on their high US prices earlier this year, Boehringer Ingelheim said Thursday that it would …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.